Wang Q - Search Results

1

CCG-1423: a small-molecule inhibitor of RhoA transcriptional signaling.

Evelyn CR, Wade SM, Wang Q, Wu M, Iñiguez-Lluhí JA, Merajver SD, Neubig RR. Evelyn CR, et al. Among authors: wang q. Mol Cancer Ther. 2007 Aug;6(8):2249-60. doi: 10.1158/1535-7163.MCT-06-0782. Mol Cancer Ther. 2007. PMID: 17699722

2

Thrombin and lysophosphatidic acid receptors utilize distinct rhoGEFs in prostate cancer cells.

Wang Q, Liu M, Kozasa T, Rothstein JD, Sternweis PC, Neubig RR. Wang Q, et al. J Biol Chem. 2004 Jul 9;279(28):28831-4. doi: 10.1074/jbc.C400105200. Epub 2004 May 13. J Biol Chem. 2004. PMID: 15143072 Free article.

3

Selectivity and anti-Parkinson's potential of thiadiazolidinone RGS4 inhibitors.

Blazer LL, Storaska AJ, Jutkiewicz EM, Turner EM, Calcagno M, Wade SM, Wang Q, Huang XP, Traynor JR, Husbands SM, Morari M, Neubig RR. Blazer LL, et al. Among authors: wang q. ACS Chem Neurosci. 2015 Jun 17;6(6):911-9. doi: 10.1021/acschemneuro.5b00063. Epub 2015 Apr 20. ACS Chem Neurosci. 2015. PMID: 25844489

4

The role of regulator of G protein signaling 4 in delta-opioid receptor-mediated behaviors.

Dripps IJ, Wang Q, Neubig RR, Rice KC, Traynor JR, Jutkiewicz EM. Dripps IJ, et al. Among authors: wang q. Psychopharmacology (Berl). 2017 Jan;234(1):29-39. doi: 10.1007/s00213-016-4432-5. Epub 2016 Sep 13. Psychopharmacology (Berl). 2017. PMID: 27624599 Free PMC article.

5

Receptor-selective effects of endogenous RGS3 and RGS5 to regulate mitogen-activated protein kinase activation in rat vascular smooth muscle cells.

Wang Q, Liu M, Mullah B, Siderovski DP, Neubig RR. Wang Q, et al. J Biol Chem. 2002 Jul 12;277(28):24949-58. doi: 10.1074/jbc.M203802200. Epub 2002 May 2. J Biol Chem. 2002. PMID: 12006602 Free article.

6

Ribozyme- and siRNA-mediated suppression of RGS-containing RhoGEF proteins.

Wang Q, Liu M, Kozasa T, Rothestein JD, Sternweis PC, Neubig RR. Wang Q, et al. Methods Enzymol. 2004;389:244-65. doi: 10.1016/S0076-6879(04)89015-3. Methods Enzymol. 2004. PMID: 15313570 Review.

7

Modulation of μ-opioid receptor signaling by RGS19 in SH-SY5Y cells.

Wang Q, Traynor JR. Wang Q, et al. Mol Pharmacol. 2013 Feb;83(2):512-20. doi: 10.1124/mol.112.081992. Epub 2012 Nov 29. Mol Pharmacol. 2013. PMID: 23197645 Free PMC article.

8

5-HT1A receptor-mediated phosphorylation of extracellular signal-regulated kinases (ERK1/2) is modulated by regulator of G protein signaling protein 19.

Wang Q, Terauchi A, Yee CH, Umemori H, Traynor JR. Wang Q, et al. Cell Signal. 2014 Sep;26(9):1846-52. doi: 10.1016/j.cellsig.2014.04.017. Epub 2014 May 2. Cell Signal. 2014. PMID: 24793302 Free PMC article.

9

Alpha 2-adrenergic agonist enrichment of spinophilin at the cell surface involves beta gamma subunits of Gi proteins and is preferentially induced by the alpha 2A-subtype.

Brady AE, Wang Q, Allen PB, Rizzo M, Greengard P, Limbird LE. Brady AE, et al. Among authors: wang q. Mol Pharmacol. 2005 May;67(5):1690-6. doi: 10.1124/mol.104.005215. Epub 2005 Feb 10. Mol Pharmacol. 2005. PMID: 15705742

10

Differential modulation of mu- and delta-opioid receptor agonists by endogenous RGS4 protein in SH-SY5Y cells.

Wang Q, Liu-Chen LY, Traynor JR. Wang Q, et al. J Biol Chem. 2009 Jul 3;284(27):18357-67. doi: 10.1074/jbc.M109.015453. Epub 2009 May 5. J Biol Chem. 2009. PMID: 19416973 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

69,381 results

Search Page